Skip to main content
FinSpry Logo
FinSpry
VYNE logo
VYNE
(NASDAQ)
VYNE Therapeutics Inc.
$28.56-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

VYNE Therapeutics (VYNE) Stock Price & Financial Analysis

VYNE Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$23.37 - $28.56
52-Week High$46.95
52-Week Low$0.28
Open$25.50
Volume93.25K
Average Volume (3M)57.05K
Market Cap1.22B
Shares Outstanding42.77M
Price to Sales (P/S)2690.43
Price to Book (P/B)49.58
EV/EBITDA-38.04
Revenue (TTM)454.00K
Net Income (TTM)-21.46M
Free Cash Flow (TTM)-25.74M
EPS (TTM)$-0.66
Profit Margin-4726.21%
Operating Margin-7044.05%
Return on Equity (ROE)-87.09%
Debt to Equity0.00
50-Day MA$34.07
200-Day MA$10.84
52-Week Change1856.16%
Annual Dividend$39.10
Dividend Yield136.90%
Last Dividend Ex-DateJul 24, 2026

Frequently Asked Questions About VYNE Therapeutics

What is the current stock price for VYNE?

As of the latest trading session, VYNE stock trades at $28.56. The 52-week range is $0.28–$46.95, with a day range of $23.37–$28.56.

What is the P/E ratio for VYNE?

The P/E ratio (Price-to-Earnings) for VYNE is shown in the Key Statistics section. This valuation metric helps compare VYNE Therapeutics Inc. to industry peers.

Does VYNE pay dividends?

Yes, VYNE Therapeutics pays a 136.90% annual dividend yield ($39.10 per share). The last ex-dividend date was 2026-07-24.

What do analysts recommend for VYNE?

Analyst ratings and recommendations for VYNE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of VYNE?

VYNE Therapeutics's market capitalization is $1.22B, classifying it as a small-cap company. VYNE Therapeutics operates in the Healthcare sector within the Biotechnology industry.